What is CannaPharmaRX, Inc. (CPMD) stock price today?

CannaPharmaRX, Inc. (CPMD) is currently trading at $0.00.

What is CPMD P/E ratio?

CannaPharmaRX, Inc.'s P/E ratio is -0.13. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is CPMD return on equity (ROE)?

CannaPharmaRX, Inc.'s return on equity (ROE) is 36.67%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is CannaPharmaRX, Inc.'s market cap?

CannaPharmaRX, Inc. has a market capitalization of $1.42M.

OTC · Drug Manufacturers - Specialty & Generic

CannaPharmaRX, Inc. (CPMD) Stock

$0.00 OTC: CPMD Healthcare

CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector.

Valuation

Metric	Value
Price	$0.00
Market Cap	$1.42M
P/E Ratio	-0.13
P/B Ratio	-0.05
P/S Ratio	1.42
EPS (TTM)	$-0.02
52-Week High	$0.01
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	36.67%
ROA	-157.14%
ROCE	13.46%
Gross Margin	-400.00%
Operating Margin	-300.00%
Net Margin	-1100.00%
Debt/Equity	-0.70
Current Ratio	0.03

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$1.0M	$1.0M
Operating Profit	$-3.0M	$-5.0M	$-2.0M	$-4.0M	$-3.0M
Net Profit	$-9.0M	$-9.0M	$4.0M	$-10.0M	$-11.0M
EPS	$-0.12	$-0.04	$0.01	$-0.02	$-0.02
Op Margin	—	—	—	-439.7%	-245.8%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$0	$5.0M	$12.0M	$11.0M	$7.0M
Total Liabilities	$13.0M	$23.0M	$24.0M	$31.0M	$37.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$9.0M	$15.0M	$13.0M	$14.0M	$21.0M

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-2.0M	$-1.0M	$-2.0M	$-2.0M	$-1.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$1.0M	$1.0M	$2.0M	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-2.0M	$-2.0M	$-2.0M	$-2.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-2.72
FCF Yield	-30.66%
Quick Ratio	0.00
Interest Coverage	-1.38
Return 1Y	-30.00%
Return 3Y	-85.00%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ALIDAllied Corp.	$0.00	—	0.00	$57748	0.00%
APPBApplied Biosciences Corp.	$0.00	—	0.00	$1365	0.00%
CBDYTarget Group Inc.	$0.00	—	-0.41	$740431	0.00%
CNNACann American Corp.	$0.01	+8.33%	0.53	$4.80M	0.00%
EXMTAnything Technologies Media, Inc.	$0.00	—	-6.00	$1.44M	0.00%

About CannaPharmaRX, Inc.

CannaPharmaRX, Inc. is a Canadian enterprise actively involved in the cannabis sector. The company focuses on identifying, acquiring, and developing diverse projects for cultivating cannabis. Founded in 1998, its main offices are located in Calgary, Canada.

CannaPharmaRX, Inc. (CPMD) stock trades at $0.00 with a market capitalization of $1.42M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.13, reflecting a net loss over the last twelve months, a negative price-to-book of -0.05, reflecting negative shareholders' equity, price-to-sales of 1.42. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, CannaPharmaRX, Inc. generates a return on equity (ROE) of 36.67% (not meaningful, as shareholders' equity is negative), return on capital employed of 13.46%, an operating margin of -300.00%, a net profit margin of -1100.00%.

Official website: www.cannapharmarx.com